Oct 13, 2023 In the News BioGenerator Company Immunophotonics Announces 1st Patient Dosed in the United States under its IND Application
Sep 19, 2023 In the News BioGenerator Company Aclaris Announces Positive Phase 1 Data for ITK/JAK3 inhibitor
Aug 26, 2023 In the News Managing Director of BioGenerator Ventures, Matt Helms, Builds Unique Ag-Food Business
Aug 15, 2023 In the News BioGenerator Company Wugen Begins Phase 1 Clinical Trial of Allogeneic Memory Natural Killer (NK) Cell Therapy
May 18, 2023 In the News BioGenerator Company Immunophotonics Receives Green Light from FDA to Open IND